Reproductive fitness in maternal homocystinuria due to cystathionine β‐synthase deficiency
Authors:
- 1 June 2002
- journal article
- Published by Wiley in Journal of Inherited Metabolic Disease
- Vol. 25 (4) , 299-314
Abstract
Early diagnosis and improved treatment are leading to the potential for increased reproductive capability in homocystinuria due to cystathionine β‐synthase (CβS) deficiency, but information about reproductive outcome and risk of thromboembolism in pregnancy is limited. To provide further information, clinical and biochemical information was obtained on women with maternal homocystinuria, on their pregnancies and on the offspring. This information included blood sulphur amino acids and total homocysteine, CβS gene mutations and developmental and cognitive scores in the offspring. The study involved 15 pregnancies in 11 women, of whom 5 were pyridoxine‐nonresponsive and 6 were pyridoxine‐responsive. Complications of pregnancy included pre‐eclampsia at term in two pregnancies and superficial venous thrombosis of the leg in a third pregnancy. One pregnancy was terminated and two pregnancies resulted in first‐trimester spontaneous abortions. The remaining 12 pregnancies produced live‐born infants with normal or above‐normal birth measurements. One offspring has multiple congenital anomalies that include colobomas of the iris and choroid, neural tube defect and undescended testes. He is also mentally retarded and autistic. A second offspring has Beckwith–Wiedemann syndrome. The remaining 10 offspring were normal at birth and have remained normal. There was no relationship between the severity of the biochemical abnormalities or the therapies during pregnancy to either the pregnancy complications or the offspring outcomes. The infrequent occurrences of pregnancy complications, offspring abnormalities and maternal thromboembolic events in this series suggest that pregnancy and outcome in maternal homocystinuria are usually normal. Nevertheless, a cautious approach would include careful monitoring of these pregnancies with attention to metabolic therapy and possibly anticoagulation.Keywords
This publication has 31 references indexed in Scilit:
- Maternal pyridoxine non‐responsive homocystinuria: the role of dietary treatment and anticoagulationBJOG: An International Journal of Obstetrics & Gynaecology, 2001
- The Molecular Basis of Cystathionine β-Synthase Deficiency in Dutch Patients with Homocystinuria: Effect of CBS Genotype on Biochemical and Clinical Phenotype and on Response to TreatmentThe American Journal of Human Genetics, 1999
- A successful pregnancy in a patient with homocystinuria and a previous near‐fatal postpartum cavernous sinus thrombosisBJOG: An International Journal of Obstetrics & Gynaecology, 1995
- Longitudinal observations on 15 children with Wiedemann‐Beckwith syndromeAmerican Journal of Medical Genetics, 1995
- High frequency (71%) of cystathionine β-synthase mutation G307S in Irish homocystinuria patientsHuman Mutation, 1995
- Brief report: A comparison of the diagnostic criteria for Asperger syndromeJournal of Autism and Developmental Disorders, 1992
- UNSUSPECTED PREGNANCY LOSS IN HEALTHY WOMENThe Lancet, 1983
- Maternal Phenylketonuria and HyperphenylalaninemiaNew England Journal of Medicine, 1980
- FETAL LOSS AFTER IMPLANTATIONThe Lancet, 1980
- MATERNAL AND FETAL PLASMA AMINO ACID CONCENTRATIONS DURING GESTATION AND IN RETARDED FETAL GROWTHBJOG: An International Journal of Obstetrics & Gynaecology, 1969